Analyses of Effects of Aficamten on Key Clinical Outcomes from SEQUOIA-HCM to be Featured in Late Breaking Clinical Trial Presentation at HFSA
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Cytokinetics (NASDAQ:), Incorporated (Nasdaq: CYTK) today announced three upcoming presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions on September 27, 2024 and one Late Breaking Clinical Trial presentation at the Heart Failure Society of America (HFSA) Annual Scientific Meeting, taking place September 27-30, 2024, both in Atlanta, GA.
2024 HCMS Scientific Sessions
Oral Abstract Presentation
Title: Global Remodeling Changes with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy: An Analysis of the SEQUOIA-HCM Trial
Presenter: Anjali T. Owens, M.D., Medical Director, Center for Inherited Cardiac Disease, Assistant Professor of Medicine, University of Pennsylvania
Date: September 27, 2024
Session Title: Oral Abstract Presentations
Session Time: 11:00 “ 12:00 PM ET
Location: Signia by Hilton, Atlanta Georgia World Congress Center
Poster Abstract Presentation
Title: Efficacy and Safety of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy and Very High Left Ventricular Outflow Tract Gradients
Presenter: Juan R. Gimeno, M.D., Consultant Cardiologist, Hospital Universitario Virgen de la Arrixaca, Associate Professor, Medicine “ Cardiology, Universidad de Murcia, Spain
Date: September 27, 2024
Session Title: Closing Remarks & Poster Cocktail Reception
Session Time: 4:00 “ 5:00 PM ET
Location: Signia by Hilton, Atlanta Georgia World Congress Center
Title: Beta-Blocker Use and Incidence of New Atrial Fibrillation or Flutter Requiring Therapy in Post-Septal Myectomy Hypertrophic Cardiomyopathy Patients
Presenter: Morris M. Kim, M.D., Cardiovascular Disease Fellow, Oregon Health & Science University
Date: September 27, 2024
Session Title: Closing Remarks & Poster Cocktail Reception
Session Time: 4:00 “ 5:00 PM ET
Location: Signia by Hilton, Atlanta Georgia World Congress Center
HFSA Annual Scientific Meeting
Title: Global Clinical Impact of Aficamten in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Presenter: Martin Maron, M.D., Director, Hypertrophic Cardiomyopathy Center, Lahey Hospital and Medical Center
Date: September 30, 2024
Session Title: Plenary Sessions – Monday Plenary Session: Late Breaking Clinical Research Session II
Session Time: 9:00 “ 10:30 AM…
Click Here to Read the Full Original Article at All News…
